Role of adipokines in cardiovascular disease

Journal of Endocrinology

Volumn 216, Issue 1, 2013, Pages

  Mattu, Harman S ^a   Randeva, Harpal S ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ADIPOCYTOKINE; ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; APELIN; CADHERIN; CHEMERIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 6; LEPTIN; LEPTIN RECEPTOR; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMENTIN; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; RESISTIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; APLN PROTEIN, HUMAN; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, HUMAN; SIGNAL PEPTIDE;

ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL ADHESION; CELL PROLIFERATION; ENDOTHELIAL DYSFUNCTION; FATTY ACID OXIDATION; GLUCONEOGENESIS; GLUCOSE METABOLISM; HEART FUNCTION; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HOMEOSTASIS; HUMAN; HYPERTENSION; HYPOADIPONECTINEMIA; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; METABOLISM; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SATIETY; VASCULAR ENDOTHELIUM; ADIPOSE TISSUE; ANIMAL; BLOOD; IMMUNOLOGY; PATHOPHYSIOLOGY; REVIEW; SECRETION (PROCESS);

ADIPOKINES; ADIPOSE TISSUE; ANIMALS; CARDIOVASCULAR DISEASES; CYTOKINES; GPI-LINKED PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LECTINS; METABOLIC SYNDROME X; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY;

MLCS; MLOWN;

EID: 84874430535     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0232     Document Type: Article

References (209)

1. Adeghate E 2004 An update on the biology and physiology of resistin. Cellular and Molecular Life Sciences 61 2485-2496.
2. Adya R, Tan BK, Punn A, Chen J & Randeva HS 2008 Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Cardiovascular Research 78 356-365.
3. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, Kumada M, Hotta K, Nishida M, Takahashi M et al. 2002 Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105 2893-2898.
4. Atluri P, Morine KJ, Liao GP, Panlilio CM, Berry MF, Hsu VM, HiesingerW, Cohen JE & Joseph Woo Y 2007 Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression. Cellular and Molecular Biology Letters 12 127-138.
5. Bae SK, Kim SR, Kim JG, Kim JY, Koo TH, Jang HO, Yun I, Yoo MA & Bae MK 2006 Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1. FEBS Letters 580 4105-4113.
6. Bailey SD, Loredo-Osti JC, Lepage P, Faith J, Fontaine J, Desbiens KM, Hudson TJ, Bouchard C, Gaudet D, Perusse L et al. 2006 Common polymorphisms in the promoter of the visfatin gene (PBEF1) influenceplasma insulin levels in a French-Canadian population. Diabetes 55 2896-2902.
7. Barandier C, Montani JP & Yang Z 2005 Mature adipocytes and perivascular adipose tissue stimulate vascular smooth muscle cell proliferation: effects of aging and obesity. American Journal of Physiology. Heart and Circulatory Physiology 289 H1807-H1813.
8. Beltowski J 2006a Leptin and atherosclerosis. Atherosclerosis 189 47-60.
9. Beltowski J 2006b Role of leptin in blood pressure regulation and arterial hypertension. Journal of Hypertension 24 789-801.
10. Berndt J, Kloting N, Kralisch S, Kovacs P, Fasshauer M, Schon MR, Stumvoll M & Bluher M 2005 Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54 2911-2916.
11. Berry MF, Pirolli TJ, Jayasankar V, Burdick J, Morine KJ, Gardner TJ & Woo YJ 2004 Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 110 II187-II193.
12. Bouloumie A, Marumo T, Lafontan M & Busse R 1999 Leptin induces oxidative stress in human endothelial cells. FASEB Journal 13 1231-1238.
13. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, Walder K & Segal D 2007 Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148 4687-4694.
14. Bozaoglu K, Curran JE, Stocker CJ, Zaibi MS, Segal D, Konstantopoulos N, Morrison S, Carless M, Dyer TD, Cole SA et al. 2010 Chemerin, a novel adipokine in the regulation of angiogenesis. Journal of Clinical Endocrinology and Metabolism 95 2476-2485.
15. Brown JE, Onyango DJ, Ramanjaneya M, Conner AC, Patel ST, Dunmore SJ & Randeva HS 2010 Visfatin regulates insulin secretion, insulin receptor signalling and mRNA expression of diabetes-related genes in mouse pancreatic b-cells. Journal of Molecular Endocrinology 44 171-178.
16. Calabro P, Samudio I, Willerson JT & Yeh ET 2004 Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation 110 3335-3340.
17. Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, Doran J, Hendrick AG, Carlton MB & Greaves DR 2008 Synthetic chemerin-derived peptides suppress inflammation through ChemR23. Journal of Experimental Medicine 205 767-775.
18. Cesari M, Pessina AC, Zanchetta M, De Toni R, Avogaro A, Pedon L, Dorigatti F, Maiolino G & Rossi GP 2006 Low plasma adiponectin is associated with coronary artery disease but not with hypertension in high-risk nondiabetic patients. Journal of Internal Medicine 260 474-483.
19. Chen MM, Ashley EA, DengDX, Tsalenko A, Deng A, Tabibiazar R, Ben-DorA, Fenster B, Yang E, King JY et al. 2003 Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 108 1432-1439.
20. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ & Lee YJ 2006 Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 91 295-299.
21. Cheng KK, Lam KS, Wang Y, Huang Y, Carling D, Wu D, Wong C & Xu A 2007 Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes 56 1387-1394.
22. Chong KS, Gardner RS, Morton JJ, Ashley EA &McDonagh TA 2006 Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure. European Journal of Heart Failure 8 355-360.
23. Chow WS, Cheung BM, Tso AW, Xu A, Wat NM, Fong CH, Ong LH, Tam S, Tan KC, Janus ED et al. 2007 Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 49 1455-1461.
24. Chun HJ, Ali ZA, Kojima Y, Kundu RK, Sheikh AY, Agrawal R, Zheng L, Leeper NJ, Pearl NE, Patterson AJ et al. 2008 Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. Journal of Clinical Investigation 118 3343-3354.
25. Dahl TB, Yndestad A, Skjelland M, Oie E, Dahl A, Michelsen A, Damas JK, Tunheim SH, Ueland T, Smith C et al. 2007 Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 115 972-980.
26. Dai T, Ramirez-Correa G & Gao WD 2006 Apelin increases contractility in failing cardiac muscle. European Journal of Pharmacology 553 222-228.
27. Dick GM, Katz PS, Farias M III, Morris M, James J, Knudson JD & Tune JD 2006 Resistin impairs endothelium-dependent dilation to bradykinin, but not acetylcholine, in the coronary circulation. American Journal of Physiology. Heart and Circulatory Physiology 291 H2997-H3002.
28. Dong F, Zhang X & Ren J 2006 Leptin regulates cardiomyocyte contractile function through endothelin-1 receptor-NADPH oxidase pathway. Hypertension 47 222-229.
29. Doyle DD, Goings GE, Upshaw-Earley J, Page E, Ranscht B & Palfrey HC 1998 T-cadherin is a major glycophosphoinositol-anchored protein associated with noncaveolar detergent-insoluble domains of the cardiac sarcolemma. Journal of Biological Chemistry 273 6937-6943.
30. Efstathiou SP, Tsiakou AG, Tsioulos DI, Panagiotou TN, Pefanis AV, Achimastos AD & Mountokalakis TD 2007 Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke. Clinica Chimica Acta 378 78-85.
31. Eguchi M, Liu Y, Shin EJ & Sweeney G 2008 Leptin protects H9c2 rat cardiomyocytes from H2O2-induced apoptosis. FEBS Journal 275 3136-3144.
32. Ellinor PT, Low AF & Macrae CA 2006 Reduced apelin levels in lone atrial fibrillation. European Heart Journal 27 222-226.
33. Enriori PJ, Evans AE, Sinnayah P & Cowley MA 2006 Leptin resistance and obesity. Obesity 14(Suppl 5) 254S-258S.
34. Erkasap N, Ikizler M, Shneyvays V, Zinman T, Mamedova LK, Uyar R & Shainberg A 2006 Leptin protects the cardiac myocyte cultures from hypoxic damage. Life Sciences 78 1098-1102.
35. Fain JN, Sacks HS, Buehrer B, Bahouth SW, Garrett E, Wolf RY, Carter RA, Tichansky DS & Madan AK 2008 Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots. International Journal of Obesity 32 810-815.
36. Farkasfalvi K, Stagg MA, Coppen SR, Siedlecka U, Lee J, Soppa GK, Marczin N, Szokodi I, Yacoub MH & Terracciano CM 2007 Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochemical and Biophysical Research Communications 357 889-895.
37. Foldes G, Horkay F, Szokodi I, Vuolteenaho O, Ilves M, Lindstedt KA, Mayranpaa M, Sarman B, Seres L, Skoumal R et al. 2003 Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochemical and Biophysical Research Communications 308 480-485.
38. Francia P, Salvati A, Balla C, De Paolis P, Pagannone E, Borro M, Gentile G, Simmaco M, De Biase L & Volpe M 2007 Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin. European Journal of Heart Failure 9 306-309.
39. Fruhbeck G 2006 Intracellular signalling pathways activated by leptin. Biochemical Journal 393 7-20.
40. Fujioka D, Kawabata K, Saito Y, Kobayashi T, Nakamura T, Kodama Y, Takano H, Obata JE, Kitta Y, Umetani K et al. 2006 Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. American Journal of Physiology. Heart and Circulatory Physiology 290 H2409-H2416.
41. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H et al. 2005 Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307 426-430.
42. Gao YJ, Zeng ZH, Teoh K, Sharma AM, Abouzahr L, Cybulsky I, Lamy A, Semelhago L & Lee RM 2005 Perivascular adipose tissue modulates vascular function in the human internal thoracic artery. Journal of Thoracic and Cardiovascular Surgery 130 1130-1136.
43. Gao J, Chang Chua C, Chen Z, Wang H, Xu X, C Hamdy R, McMullen JR, Shioi T, Izumo S & Chua BH 2007 Resistin, an adipocytokine, offers protection against acute myocardial infarction. Journal of Molecular and Cellular Cardiology 43 601-609.
44. Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, Muruganandan S & Sinal CJ 2007 Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. Journal of Biological Chemistry 282 28175-28188.
45. Graveleau C, Zaha VG, Mohajer A, Banerjee RR, Dudley-Rucker N, Steppan CM, Rajala MW, Scherer PE, Ahima RS, Lazar MA et al. 2005 Mouse and human resistins impair glucose transport in primary mouse cardiomyocytes, and oligomerization is required for this biological action. Journal of Biological Chemistry 280 31679-31685.
46. Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, Laing I, Yates AP, Pemberton PW, Malik RA et al. 2009 Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 119 1661-1670.
47. Habata Y, Fujii R, Hosoya M, Fukusumi S, Kawamata Y, Hinuma S, Kitada C, Nishizawa N, Murosaki S, Kurokawa T et al. 1999 Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochimica et Biophysica Acta 1452 25-35.
48. Haider DG, Pleiner J, Francesconi M, Wiesinger GF, Muller M & Wolzt M 2006 Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes. Journal of Clinical Endocrinology and Metabolism 91 4702-4704.
49. Halestrap AP, Clarke SJ & Javadov SA 2004 Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovascular Research 61 372-385.
50. Hall JE 2003 The kidney, hypertension, and obesity. Hypertension 41 625-633.
51. Hare JM & Stamler JS 2005 NO/redox disequilibrium in the failing heart and cardiovascular system. Journal of Clinical Investigation 115 509-517.
52. Hausenloy DJ 2009 Drug discovery possibilities from visfatin cardioprotection? Current Opinion in Pharmacology 9 202-207
53. Hausenloy DJ & Yellon DM 2006 Survival kinases in ischemic preconditioning and postconditioning. Cardiovascular Research 70 240-253.
54. Hausenloy DJ & Yellon DM 2009 Cardioprotective growth factors. Cardiovascular Research 83 179-194.
55. Heinonen MV, Purhonen AK, Miettinen P, Paakkonen M, Pirinen E, Alhava E, Akerman K & Herzig KH 2005 Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding. Regulatory Peptides 130 7-13.
56. Higuchi K, Masaki T, Gotoh K, Chiba S, Katsuragi I, Tanaka K, Kakuma T & Yoshimatsu H 2007 Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology 148 2690-2697.
57. Hopkins TA, Ouchi N, Shibata R & Walsh K 2007 Adiponectin actions in the cardiovascular system. Cardiovascular Research 74 11-18.
58. Howard JK, Lord GM, Matarese G, Vendetti S, Ghatei MA, Ritter MA, Lechler RI & Bloom SR 1999 Leptin protects mice from starvationinduced lymphoid atrophy and increases thymic cellularity in ob/ob mice. Journal of Clinical Investigation 104 1051-1059.
59. Hu E, Liang P & Spiegelman BM 1996 AdipoQ is a novel adipose-specific gene dysregulated in obesity. Journal of Biological Chemistry 271 10697-10703.
60. Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS & Lodish HF 2004 T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. PNAS 101 10308-10313.
61. Hughes JM, Riddle MA, Paffett ML, Gonzalez Bosc LV & Walker BR 2010 Novel role of endothelial BKCa channels in altered vasoreactivity following hypoxia. American Journal of Physiology. Heart and Circulatory Physiology 299 H1439-H1450.
62. Iwanaga Y, Kihara Y, Takenaka H & Kita T 2006 Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system. Journal of Molecular and Cellular Cardiology 41 798-806.
63. Japp AG, Cruden NL, Barnes G, van Gemeren N, Mathews J, Adamson J, Johnston NR, Denvir MA, Megson IL, Flapan AD et al. 2010 Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure. Circulation 121 1818-1827.
64. Jia YX, Pan CS, Zhang J, Geng B, Zhao J, Gerns H, Yang J, Chang JK, Tang CS & Qi YF 2006 Apelin protects myocardial injury induced by isoproterenol in rats. Regulatory Peptides 133 147-154.
65. Jung HS, Park KH, Cho YM, Chung SS, Cho HJ, Cho SY, Kim SJ, Kim SY, Lee HK & Park KS 2006 Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovascular Research 69 76-85.
66. Kadowaki T & Yamauchi T 2005 Adiponectin and adiponectin receptors. Endocrine Reviews 26 439-451.
67. Karmazyn M, Purdham DM, Rajapurohitam V & Zeidan A 2008 Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart. Cardiovascular Research 79 279-286.
68. Katugampola SD, Maguire JJ, Matthewson SR & Davenport AP 2001 [(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. British Journal of Pharmacology 132 1255-1260.
69. Kaur J, Adya R, Tan BK, Chen J & Randeva HS 2010 Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerininduced endothelial angiogenesis. Biochemical and Biophysical Research Communications 391 1762-1768.
70. Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, Manabe I, Utsunomiya K & Nagai R 2004 Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochemical and Biophysical Research Communications 314 415-419.
71. Kido M, Du L, Sullivan CC, Li X, Deutsch R, Jamieson SW & Thistlethwaite PA 2005 Hypoxia-inducible factor 1-a reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. Journal of the American College of Cardiology 46 2116-2124.
72. Kim JA, Montagnani M, Koh KK & Quon MJ 2006 Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113 1888-1904.
73. Kimura M, Tanaka S, Isoda F, Sekigawa K, Yamakawa T & Sekihara H 1998 T lymphopenia in obese diabetic (db/db) mice is non-selective and thymus independent. Life Sciences 62 1243-1250.
74. Kleinz MJ & Baxter GF 2008 Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase. Regulatory Peptides 146 271-277.
75. Kleinz MJ & Davenport AP 2004 Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regulatory Peptides 118 119-125.
76. Kleinz MJ & Davenport AP 2005 Emerging roles of apelin in biology and medicine. Pharmacology & Therapeutics 107 198-211.
77. Kloting N & Kloting I 2005 Visfatin: gene expression in isolated adipocytes and sequence analysis in obeseWOKWrats compared with lean control rats. Biochemical and Biophysical Research Communications 332 1070-1072.
78. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T & Matsuzawa Y 2004 Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circulation Research 94 e27-e31.
79. Kojima S, Funahashi T, Sakamoto T, Miyamoto S, Soejima H, Hokamaki J, Kajiwara I, Sugiyama S, Yoshimura M, Fujimoto K et al. 2003 The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart 89 667.
80. Kuba K, Zhang L, Imai Y, Arab S, Chen M, Maekawa Y, Leschnik M, Leibbrandt A, Markovic M, Schwaighofer J et al. 2007 Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload. Circulation Research 101 e32-e42.
81. Kunnari A, Ukkola O, Paivansalo M & Kesaniemi YA 2006 High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. Journal of Clinical Endocrinology and Metabolism 91 2755-2760.
82. Kusminski CM, McTernan PG & Kumar S 2005 Role of resistin in obesity, insulin resistance and type II diabetes. Clinical Science 109 243-256.
83. Lago F, Dieguez C, Gomez-Reino J & Gualillo O 2007 The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine & Growth Factor Reviews 18 313-325.
84. Lau DC, Dhillon B, Yan H, Szmitko PE & Verma S 2005 Adipokines: molecular links between obesity and atheroslcerosis. American Journal of Physiology. Heart and Circulatory Physiology 288 H2031-H2041.
85. Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y, Osmond DH, George SR & O'Dowd BF 2000 Characterization of apelin, the ligand for the APJ receptor. Journal of Neurochemistry 74 34-41.
86. Lee Y, Naseem RH, Duplomb L, Park BH, Garry DJ, Richardson JA, Schaffer JE & Unger RH 2004 Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice. PNAS 101 13624-13629.
87. Lee DK, George SR & O'Dowd BF 2006 Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity. Trends in Pharmacological Sciences 27 190-194.
88. Leeper NJ, Tedesco MM, Kojima Y, Schultz GM, Kundu RK, Ashley EA, Tsao PS, Dalman RL & Quertermous T 2009 Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation. American Journal of Physiology. Heart and Circulatory Physiology 296 H1329-H1335.
89. Lehrke M, Becker A, Greif M, Stark R, Laubender RP, von Ziegler F, Lebherz C, Tittus J, Reiser M, Becker C et al. 2009 Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. European Journal of Endocrinology 161 339-344.
90. Li L, Mamputu JC, Wiernsperger N & Renier G 2005 Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin. Diabetes 54 2227-2234.
91. Lim SY, Davidson SM, Paramanathan AJ, Smith CC, Yellon DM & Hausenloy DJ 2008 The novel adipocytokine visfatin exerts direct cardioprotective effects. Journal of Cellular and Molecular Medicine 12 1395-1403.
92. Lobato NS, Neves KB, Filgueira FP, Fortes ZB, Carvalho MH, Webb RC, Oliveira AM & Tostes RC 2012 The adipokine chemerin augments vascular reactivity to contractile stimuli via activation of the MEKERK1/ 2 pathway. Life Sciences 91 600-606.
93. Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M & Sharma AM 2002 Periadventitial fat releases a vascular relaxing factor. FASEB Journal 16 1057-1063.
94. Lubos E, Messow CM, Schnabel R, Rupprecht HJ, Espinola-Klein C, Bickel C, Peetz D, Post F, Lackner KJ, Tiret L et al. 2007 Resistin, acute coronary syndrome and prognosis results from the AtheroGene study. Atherosclerosis 193 121-128.
95. Madani S, De Girolamo S, Munoz DM, Li RK & Sweeney G 2006 Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes. Cardiovascular Research 69 716-725.
96. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y & Matsubara K 1996 cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochemical and Biophysical Research Communications 221 286-289.
97. Malinowski M, Deja MA, Golba KS, Roleder T, Biernat J & Wos S 2008 Perivascular tissue of internal thoracic artery releases potent nitric oxide and prostacyclin-independent anticontractile factor. European Journal of Cardio-Thoracic Surgery 33 225-231.
98. Masri B, Lahlou H, Mazarguil H, Knibiehler B & Audigier Y 2002 Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein. Biochemical and Biophysical Research Communications 290 539-545.
99. Masri B, Morin N, Cornu M, Knibiehler B & Audigier Y 2004 Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB Journal 18 1909-1911.
100. Matsuda K, Teragawa H, Fukuda Y, Nakagawa K, Higashi Y & Chayama K 2003 Leptin causes nitric-oxide independent coronary artery vasodilation in humans. Hypertension Research 26 147-152.
101. McGaffinKR, SunCK, Rager JJ, RomanoLC, ZouB, MathierMA, O'DohertyRM, McTiernan CF & O'Donnell CP 2008 Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury. Cardiovascular Research 77 54-63.
102. Milan G, Granzotto M, Scarda A, Calcagno A, Pagano C, Federspil G & Vettor R 2002 Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obesity Research 10 1095-1103.
103. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D & Kahn BB 2002 Leptin stimulates fatty-acid oxidation by activating AMPactivated protein kinase. Nature 415 339-343.
104. Momin AU, Melikian N, Shah AM, Grieve DJ, Wheatcroft SB, John L, El Gamel A, Desai JB, Nelson T, Driver C et al. 2006 Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: evidence for tissue specificity of leptin resistance. European Heart Journal 27 2294-2299.
105. Montagnani M, Ravichandran LV, Chen H, Esposito DL & Quon MJ 2002 Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. Molecular Endocrinology 16 1931-1942.
106. Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H & Tilg H 2007 Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. Journal of Immunology 178 1748-1758.
107. Mu H, Ohashi R, Yan S, Chai H, Yang H, Lin P, Yao Q & Chen C 2006 Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovascular Research 70 146-157.
108. Nagpal S, Patel S, Jacobe H, DiSepio D, Ghosn C, Malhotra M, Teng M, Duvic M & Chandraratna RA 1997 Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. Journal of Investigative Dermatology 109 91-95.
109. Nakano Y, Tobe T, Choi-Miura NH, Mazda T & Tomita M 1996 Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. Journal of Biochemistry 120 803-812.
110. Nickola MW, Wold LE, Colligan PB, Wang GJ, Samson WK & Ren J 2000 Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO. Hypertension 36 501-505.
111. Norata GD, Ongari M, Garlaschelli K, Raselli S, Grigore L & Catapano AL 2007 Plasma resistin levels correlate with determinants of the metabolic syndrome. European Journal of Endocrinology 156 279-284.
112. Oda A, Taniguchi T & Yokoyama M 2001 Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe Journal of Medical Sciences 47 141-150.
113. O'Dowd BF, Heiber M, Chan A, Heng HH, Tsui LC, Kennedy JL, Shi X, Petronis A, George SR & Nguyen T 1993 A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136 355-360.
114. Ognjanovic S, Bao S, Yamamoto SY, Garibay-Tupas J, Samal B & Bryant-Greenwood GD 2001 Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetalmembranes. Journal of Molecular Endocrinology 26 107-117.
115. Ohashi K, Kihara S, Ouchi N, KumadaM, Fujita K, Hiuge A, Hibuse T, Ryo M, Nishizawa H, Maeda N et al. 2006 Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 47 1108-1116.
116. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T et al. 1999 Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 2473-2476.
117. Ouchi N, Kihara S, Arita Y, NishidaM, Matsuyama A, Okamoto Y, IshigamiM, Kuriyama H, Kishida K, Nishizawa H et al. 2001 Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103 1057-1063.
118. Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, Nagaretani H, Kumada M, Ohashi K, Okamoto Y, Nishizawa H et al. 2003 Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 42 231-234.
119. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, Funahashi T & Walsh K 2004 Adiponectin stimulates angiogenesis by promoting crosstalk between AMP-activated protein kinase and Akt signaling in endothelial cells. Journal of Biological Chemistry 279 1304-1309.
120. Ouchi N, Shibata R & Walsh K 2006 Cardioprotection by adiponectin. Trends in Cardiovascular Medicine 16 141-146.
121. Ouedraogo R, Gong Y, Berzins B, Wu X, Mahadev K, Hough K, Chan L, Goldstein BJ & Scalia R 2007 Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. Journal of Clinical Investigation 117 1718-1726.
122. Palanivel R, Eguchi M, Shuralyova I, Coe I & Sweeney G 2006 Distinct effects of short- and long-term leptin treatment on glucose and fatty acid uptake and metabolism in HL-1 cardiomyocytes. Metabolism 55 1067-1075.
123. Pineiro R, Iglesias MJ, Gallego R, Raghay K, Eiras S, Rubio J, Dieguez C, Gualillo O, Gonzalez-Juanatey JR & Lago F 2005 Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Letters 579 5163-5169.
124. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB & Rimm EB 2004 Plasma adiponectin levels and risk of myocardial infarction in men. Journal of the American Medical Association 291 1730-1737.
125. Pischon T, Bamberger CM, Kratzsch J, Zyriax BC, Algenstaedt P, Boeing H & Windler E 2005 Association of plasma resistin levels with coronary heart disease in women. Obesity Research 13 1764-1771.
126. Purdham DM, Zou MX, Rajapurohitam V & KarmazynM2004 Rat heart is a site of leptin production and action. American Journal of Physiology. Heart and Circulatory Physiology 287 H2877-H2884.
127. Qi Y, Nie Z, Lee YS, Singhal NS, Scherer PE, Lazar MA & Ahima RS 2006 Loss of resistin improves glucose homeostasis in leptin deficiency. Diabetes 55 3083-3090.
128. Rajala MW, Qi Y, Patel HR, Takahashi N, Banerjee R, Pajvani UB, Sinha MK, Gingerich RL, Scherer PE & Ahima RS 2004 Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 53 1671-1679.
129. Rajapurohitam V, Gan XT, Kirshenbaum LA & Karmazyn M 2003 The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circulation Research 93 277-279.
130. Ren J 2004 Leptin and hyperleptinemia - from friend to foe for cardiovascular function. Journal of Endocrinology 181 1-10.
131. Rodriguez A, Fortuno A, Gomez-Ambrosi J, Zalba G, Diez J & Fruhbeck G 2007 The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism. Endocrinology 148 324-331.
132. Roh SG, Song SH, Choi KC, Katoh K, Wittamer V, Parmentier M & Sasaki S 2007 Chemerin - a new adipokine that modulates adipogenesis via its own receptor. Biochemical and Biophysical Research Communications 362 1013-1018.
133. Ronkainen VP, Ronkainen JJ, Hanninen SL, Leskinen H, Ruas JL, Pereira T, Poellinger L, Vuolteenaho O & Tavi P 2007 Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB Journal 21 1821-1830.
134. Rothwell SE, Richards AM & Pemberton CJ 2006 Resistin worsens cardiac ischaemia-reperfusion injury. Biochemical and Biophysical Research Communications 349 400-407.
135. Rutkowski JM, Davis KE & Scherer PE 2009 Mechanisms of obesity and related pathologies: the macro- and microcirculation of adipose tissue. FEBS Journal 276 5738-5746.
136. Sacks HS & Fain JN 2007 Human epicardial adipose tissue: a review. American Heart Journal 153 907-917.
137. Sahu A 2004 Minireview: a hypothalamic role in energy balance with special emphasis on leptin. Endocrinology 145 2613-2620.
138. Samal B, Sun Y, Stearns G, Xie C, Suggs S & McNiece I 1994 Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Molecular and Cellular Biology 14 1431-1437.
139. Samson M, Edinger AL, Stordeur P, Rucker J, Verhasselt V, Sharron M, Govaerts C, Mollereau C, Vassart G, Doms RW et al. 1998 ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains. European Journal of Immunology 28 1689-1700.
140. Saremi A, Asghari M & Ghorbani A 2010 Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men. Journal of Sports Sciences 28 993-998.
141. Sato N, Kobayashi K, Inoguchi T, Sonoda N, Imamura M, Sekiguchi N, Nakashima N & Nawata H 2005 Adenovirus-mediated high expression of resistin causes dyslipidemia in mice. Endocrinology 146 273-279.
142. Satoh N, Ogawa Y, Katsuura G, Numata Y, Tsuji T, Hayase M, Ebihara K, Masuzaki H, Hosoda K, Yoshimasa Y et al. 1999 Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion. Diabetes 48 1787-1793.
143. Schaffler A, Neumeier M, Herfarth H, Furst A, Scholmerich J & Buchler C 2005 Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochimica et Biophysica Acta 1732 96-102.
144. Scherer PE, Williams S, Fogliano M, Baldini G & Lodish HF 1995 A novel serum protein similar to C1q, produced exclusively in adipocytes. Journal of Biological Chemistry 270 26746-26749.
145. Schulze MB, Shai I, Rimm EB, Li T, Rifai N & Hu FB 2005 Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes 54 534-539.
146. Scott IC, Masri B, D'Amico LA, Jin SW, Jungblut B, Wehman AM, Baier H, Audigier Y & Stainier DY 2007 The G protein-coupled receptor agtrl1b regulates early development of myocardial progenitors. Developmental Cell 12 403-413.
147. Segawa K, Fukuhara A, Hosogai N, Morita K, Okuno Y, Tanaka M, Nakagawa Y, Kihara S, Funahashi T, Komuro R et al. 2006 Visfatin in adipocytes is upregulated by hypoxia through HIF1a-dependent mechanism. Biochemical and Biophysical Research Communications 349 875-882.
148. Sell H, Divoux A, Poitou C, Basdevant A, Bouillot JL, Bedossa P, Tordjman J, Eckel J & Clement K 2010 Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. Journal of Clinical Endocrinology and Metabolism 95 2892-2896.
149. Sethi JK & Vidal-Puig A 2005 Visfatin: the missing link between intraabdominal obesity and diabetes? Trends in Molecular Medicine 11 344-347
150. Shek EW, Brands MW & Hall JE 1998 Chronic leptin infusion increases arterial pressure. Hypertension 31 409-414.
151. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, Kumada M, Sato K, Schiekofer S, Ohashi K et al. 2004 Adiponectin-mediated modulation of hypertrophic signals in the heart. Nature Medicine 10 1384-1389.
152. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N & Walsh K 2005 Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nature Medicine 11 1096-1103.
153. Shibata R, Izumiya Y, Sato K, Papanicolaou K, Kihara S, ColucciWS, Sam F, Ouchi N & Walsh K 2007 Adiponectin protects against the development of systolic dysfunction following myocardial infarction. Journal of Molecular and Cellular Cardiology 42 1065-1074.
154. Shimada K, Miyazaki T & Daida H 2004 Adiponectin and atherosclerotic disease. Clinica Chimica Acta 344 1-12.
155. Shirasaka T, Takasaki M & Kannan H 2003 Cardiovascular effects of leptin and orexins. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 284 R639-R651.
156. Sierra-Johnson J, Romero-Corral A, Lopez-Jimenez F, Gami AS, Sert Kuniyoshi FH, Wolk R & Somers VK 2007 Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population. American Journal of Cardiology 100 234-239.
157. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL & Murphy LJ 2003 Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. European Journal of Endocrinology 149 331-335.
158. Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S & Ehtesham NZ 2005 Human resistin stimulates the pro-inflammatory cytokines TNF-a and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochemical and Biophysical Research Communications 334 1092-1101.
159. Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM & Smith CC 2007 Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury. Basic Research in Cardiology 102 518-528.
160. Singh P, Hoffmann M, Wolk R, Shamsuzzaman AS & Somers VK 2007 Leptin induces C-reactive protein expression in vascular endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 27 e302-e307.
161. Skurk T, Alberti-Huber C, Herder C & Hauner H 2007 Relationship between adipocyte size and adipokine expression and secretion. Journal of Clinical Endocrinology and Metabolism 92 1023-1033.
162. Smith CC, Mocanu MM, Davidson SM, Wynne AM, Simpkin JC & Yellon DM 2006a Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. British Journal of Pharmacology 149 5-13.
163. Smith J, Al-Amri M, Sniderman A & Cianflone K 2006b Visfatin concentration in Asian Indians is correlated with high density lipoprotein cholesterol and apolipoprotein A1. Clinical Endocrinology 65 667-672.
164. Smith CC, Mocanu MM, Bowen J, Wynne AM, Simpkin JC, Dixon RA, CooperMB & Yellon DM2007 Temporal changes in myocardial salvage kinases during reperfusion following ischemia: studies involving the cardioprotective adipocytokine apelin. Cardiovascular Drugs and Therapy 21 409-414.
165. Smith CC, Dixon RA, Wynne AM, Theodorou L, Ong SG, Subrayan S, Davidson SM, Hausenloy DJ & Yellon DM 2010 Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore. American Journal of Physiology. Heart and Circulatory Physiology 299 H1265-H1270.
166. Smith CC, Lim SY, Wynne AM, Sivaraman V, Davidson SM, Mocanu MM, Hausenloy DJ & Yellon DM 2011 Failure of the adipocytokine, resistin, to protect the heart from ischemia-reperfusion injury. Journal of Cardiovascular Pharmacology and Therapeutics 16 63-71.
167. Soltis EE & Cassis LA 1991 Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clinical and Experimental Hypertension 13 277-296.
168. Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, Garcia-Almeida JM, Garcia-Arnes J, Tinahones FJ & Garcia-Fuentes E 2009 Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obesity Surgery 19 1574-1580.
169. de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman M et al. 2007 Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56 1655-1661.
170. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS & Lazar MA 2001 The hormone resistin links obesity to diabetes. Nature 409 307-312.
171. Szokodi I, Tavi P, Foldes G, Voutilainen-Myllyla S, Ilves M, Tokola H, Pikkarainen S, Piuhola J, Rysa J, Toth M et al. 2002 Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circulation Research 91 434-440.
172. Taheri S, Murphy K, Cohen M, Sujkovic E, Kennedy A, Dhillo W, Dakin C, Sajedi A, GhateiM& Bloom S 2002 The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochemical and Biophysical Research Communications 291 1208-1212.
173. Tajmir P, Ceddia RB, Li RK, Coe IR & Sweeney G 2004 Leptin increases cardiomyocyte hyperplasia via extracellular signal-regulated kinaseand phosphatidylinositol 3-kinase-dependent signaling pathways. Endocrinology 145 1550-1555.
174. Takahashi T, Saegusa S, Sumino H, Nakahashi T, Iwai K, Morimoto S, Nojima T & Kanda T 2005 Adiponectin, T-cadherin and tumour necrosis factor-a in damaged cardiomyocytes from autopsy specimens. Journal of International Medical Research 33 236-244.
175. Takahashi M, Takahashi Y, Takahashi K, Zolotaryov FN, Hong KS, Kitazawa R, Iida K, Okimura Y, Kaji H, Kitazawa S et al. 2008 Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Letters 582 573-578.
176. Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y & Inukai T 2007 Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. Metabolism 56 451-458.
177. Tan BK, Adya R, Farhatullah S, Chen J, Lehnert H & Randeva HS 2010 Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes 59 3023-3031.
178. Tao L, Gao E, Jiao X, Yuan Y, Li S, Christopher TA, Lopez BL, Koch W, Chan L, Goldstein BJ et al. 2007 Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/ nitrative stress. Circulation 115 1408-1416.
179. Tasci I, Erdem G, Ozgur G, Tapan S, Dogru T, Genc H, Acikel C, Ozgurtas T & Sonmez A 2009 LDL-cholesterol lowering increases plasma apelin in isolated hypercholesterolemia. Atherosclerosis 204 222-228.
180. Tatemoto K, Takayama K, Zou MX, Kumaki I, Zhang W, Kumano K & Fujimiya M 2001 The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regulatory Peptides 99 87-92.
181. Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang C, Itani SI, Lodish HF & Ruderman NB 2002 Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. PNAS 99 16309-16313.
182. Trujillo ME & Scherer PE 2006 Adipose tissue-derived factors: impact on health and disease. Endocrine Reviews 27 762-778.
183. Tsioufis C, Dimitriadis K, Selima M, Thomopoulos C, Mihas C, Skiadas I, Tousoulis D, Stefanadis C & Kallikazaros I 2007 Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients. European Heart Journal 28 1162-1169.
184. Unger RH 2002 Lipotoxic diseases. Annual Review of Medicine 53 319-336.
185. van der Veer E, Nong Z, O'Neil C, Urquhart B, Freeman D & Pickering JG 2005 Pre-B-cell colony-enhancing factor regulates NADC-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation. Circulation Research 97 25-34.
186. Wang P, Xu TY, Guan YF, Su DF, Fan GR & Miao CY 2009 Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovascular Research 81 370-380.
187. Wannamethee SG, Tchernova J, Whincup P, Lowe GD, Kelly A, Rumley A, Wallace AM & Sattar N 2007 Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis 191 418-426.
188. Weikert C, Westphal S, Berger K, Dierkes J, Mohlig M, Spranger J, Rimm EB, Willich SN, Boeing H & Pischon T 2008 Plasma resistin levels and risk of myocardial infarction and ischemic stroke. Journal of Clinical Endocrinology and Metabolism 93 2647-2653.
189. Weir RA, Chong KS, Dalzell JR, Petrie CJ, Murphy CA, Steedman T, Mark PB, McDonagh TA, Dargie HJ & McMurray JJ 2009 Plasma apelin concentration is depressed following acute myocardial infarction in man. European Journal of Heart Failure 11 551-558.
190. Withers SB, Agabiti-Rosei C, Livingstone DM, Little MC, Aslam R, Malik RA & Heagerty AM 2011 Macrophage activation is responsible for loss of anticontractile function in inflamed perivascular fat. Arteriosclerosis, Thrombosis, and Vascular Biology 31 908-913.
191. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, Brezillon S, Tyldesley R, Blanpain C, Detheux M et al. 2003 Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. Journal of Experimental Medicinex 198 977-985.
192. Wulster-Radcliffe MC, Ajuwon KM, Wang J, Christian JA & Spurlock ME 2004 Adiponectin differentially regulates cytokines in porcine macrophages. Biochemical and Biophysical Research Communications 316 924-929.
193. Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M & Brownlee M 2001 Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. Journal of Biological Chemistry 276 25096-25100.
194. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K et al. 2002 Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine 8 1288-1295.
195. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K, Matsui J et al. 2003 Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. Journal of Biological Chemistry 278 2461-2468.
196. Yamawaki H, Hara N, OkadaM& Hara Y 2009 Visfatin causes endotheliumdependent relaxation in isolated blood vessels. Biochemical and Biophysical Research Communications 383 503-508.
197. Yamawaki H, Tsubaki N, Mukohda M, Okada M & Hara Y 2010 Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochemical and Biophysical Research Communications 393 668-672.
198. Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M & Hara Y 2011 Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochemical and BiophysicalResearch Communications 408 339-343.
199. Yamawaki H, Kameshima S, Usui T, Okada M & Hara Y 2012 A novel adipocytokine, chemerin exerts anti-inflammatory roles in human vascular endothelial cells. Biochemical and Biophysical Research Communications 423 152-157.
200. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, Shuldiner AR, Fried SK, McLenithan JC & Gong DW 2006 Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. American Journal of Physiology. Endocrinology and Metabolism 290 E1253-E1261.
201. Yellon DM & Hausenloy DJ 2007 Myocardial reperfusion injury. New England Journal of Medicine 357 1121-1135.
202. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner AJ, Tomiyama Y et al. 2000 Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96 1723-1732.
203. Yoo HJ, Choi HY, Yang SJ, Kim HY, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS & Baik SH 2012 Circulating chemerin level is independently correlated with arterial stiffness. Journal of Atherosclerosis and Thrombosis 19 59-66 (discussion 67-58).
204. Yudkin JS, Eringa E & Stehouwer CD 2005 "Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 365 1817-1820.
205. Zabeau L, Lavens D, Peelman F, Eyckerman S, Vandekerckhove J & Tavernier J 2003 The ins and outs of leptin receptor activation. FEBS Letters 546 45-50.
206. Zabel BA, Allen SJ, Kulig P, Allen JA, Cichy J, Handel TM& Butcher EC 2005 Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. Journal of Biological Chemistry 280 34661-34666.
207. Zabel BA, Zuniga L, Ohyama T, Allen SJ, Cichy J, Handel TM & Butcher EC 2006 Chemoattractants, extracellular proteases, and the integrated host defense response. Experimental Hematology 34 1021-1032.
208. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L & Friedman JM 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372 425-432.
209. Zhang J, Ren CX, Qi YF, Lou LX, Chen L, Zhang LK, Wang X & Tang C 2006 Exercise training promotes expression of apelin and APJ of cardiovascular tissues in spontaneously hypertensive rats. Life Sciences 79 1153-1159.